BridgeMD
New treatment option for Lower Limb Amputation Below Knee (Injury)
Official title Human-Prosthetic Interaction: Brain & Technology After Lower-Limb Loss
ClinicalTrials.gov ID: NCT05818410
What this study is testing
- What it's testing
- This study evaluates brain neuroplasticity and functional performance in people with unilateral lower limb amputation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Unilateral transtibial (below knee) amputation
- Healthy subject
- Medicare Functional Classification Level: K3-4
You likely can't join if
- Any neurological disease
- Upper limb or bilateral amputation
- Osso-integration
- Metal implants
- Diabetes
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.